SIMILAR PATTERNS OF AMINO ACIDS FOR 3QWU_A_ADNA501_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1s68 | RNA LIGASE 2 (Escherichiavirus T4) |
PF09414(RNA_ligase) | 6 | LYS A 35ASN A 40ARG A 55PHE A 119VAL A 207LYS A 225 | AMP A 301 (-2.8A)AMP A 301 (-3.9A)AMP A 301 (-2.7A)AMP A 301 (-3.7A)AMP A 301 (-4.1A)AMP A 301 (-2.5A) | 1.11A | 3qwuA-1s68A:11.9 | 3qwuA-1s68A:20.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1s68 | RNA LIGASE 2 (Escherichiavirus T4) |
PF09414(RNA_ligase) | 8 | TYR A 5LYS A 35ASN A 40GLU A 99PHE A 119VAL A 207LYS A 209LYS A 225 | NoneAMP A 301 (-2.8A)AMP A 301 (-3.9A)AMP A 301 (-3.1A)AMP A 301 (-3.7A)AMP A 301 (-4.1A)AMP A 301 ( 4.9A)AMP A 301 (-2.5A) | 0.63A | 3qwuA-1s68A:11.9 | 3qwuA-1s68A:20.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1x9n | DNA LIGASE I (Homo sapiens) |
PF01068(DNA_ligase_A_M)PF04675(DNA_ligase_A_N)PF04679(DNA_ligase_A_C) | 6 | GLU A 566LYS A 568ARG A 589GLU A 621LYS A 725LYS A 744 | None | 0.91A | 3qwuA-1x9nA:11.1 | 3qwuA-1x9nA:19.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1x9n | DNA LIGASE I (Homo sapiens) |
PF01068(DNA_ligase_A_M)PF04675(DNA_ligase_A_N)PF04679(DNA_ligase_A_C) | 6 | GLU A 566LYS A 568GLU A 621PHE A 660LYS A 725LYS A 744 | None | 0.82A | 3qwuA-1x9nA:11.1 | 3qwuA-1x9nA:19.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xdn | RNA EDITING LIGASEMP52 (Trypanosomabrucei) |
PF09414(RNA_ligase) | 7 | ILE A 61LYS A 87ASN A 92ARG A 111PHE A 209VAL A 286LYS A 307 | ATP A 501 (-4.2A)ATP A 501 (-2.9A)ATP A 501 (-3.8A)ATP A 501 (-2.8A)ATP A 501 (-3.6A)ATP A 501 (-4.4A)ATP A 501 (-2.7A) | 1.05A | 3qwuA-1xdnA:10.8 | 3qwuA-1xdnA:20.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xdn | RNA EDITING LIGASEMP52 (Trypanosomabrucei) |
PF09414(RNA_ligase) | 8 | TYR A 58ILE A 61LYS A 87ASN A 92GLU A 159PHE A 209VAL A 286LYS A 307 | ATP A 501 (-4.7A)ATP A 501 (-4.2A)ATP A 501 (-2.9A)ATP A 501 (-3.8A)ATP A 501 (-3.1A)ATP A 501 (-3.6A)ATP A 501 (-4.4A)ATP A 501 (-2.7A) | 0.63A | 3qwuA-1xdnA:10.8 | 3qwuA-1xdnA:20.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1zun | SULFATE ADENYLATETRANSFERASE, SUBUNIT1/ADENYLYLSULFATEKINASE (Pseudomonassyringae groupgenomosp. 3) |
PF00009(GTP_EFTU) | 5 | ILE B 314PHE B 261VAL B 248VAL B 278LYS B 283 | None | 1.22A | 3qwuA-1zunB:undetectable | 3qwuA-1zunB:22.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2c5u | RNA LIGASE (Escherichiavirus T4) |
PF09511(RNA_lig_T4_1) | 5 | LYS A 99GLU A 159VAL A 206VAL A 230LYS A 240 | APC A1375 (-2.7A)APC A1375 (-2.9A)NoneAPC A1375 (-4.5A)APC A1375 (-2.7A) | 0.72A | 3qwuA-2c5uA:15.6 | 3qwuA-2c5uA:22.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2cfm | THERMOSTABLE DNALIGASE (Pyrococcusfuriosus) |
PF01068(DNA_ligase_A_M)PF04675(DNA_ligase_A_N)PF04679(DNA_ligase_A_C) | 7 | GLU A 247LYS A 249ARG A 269GLU A 299PHE A 339LYS A 403LYS A 420 | AMP A1563 (-4.0A)AMP A1563 (-3.5A)AMP A1563 (-3.4A)AMP A1563 ( 3.0A)AMP A1563 (-3.3A)AMP A1563 (-2.8A)AMP A1563 (-2.8A) | 0.81A | 3qwuA-2cfmA:10.6 | 3qwuA-2cfmA:21.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2hvq | HYPOTHETICAL 37.6KDA PROTEIN INGP24-HOC INTERGENICREGION (Escherichiavirus T4) |
PF09414(RNA_ligase) | 5 | ASN A 40ARG A 55PHE A 119VAL A 207LYS A 225 | APK A 35 ( 3.7A)APK A 35 ( 2.8A)APK A 35 ( 3.7A)APK A 35 ( 4.1A)APK A 35 ( 3.4A) | 0.99A | 3qwuA-2hvqA:11.8 | 3qwuA-2hvqA:23.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2hvq | HYPOTHETICAL 37.6KDA PROTEIN INGP24-HOC INTERGENICREGION (Escherichiavirus T4) |
PF09414(RNA_ligase) | 7 | TYR A 5ASN A 40GLU A 99PHE A 119VAL A 207LYS A 209LYS A 225 | NoneAPK A 35 ( 3.7A)APK A 35 ( 3.3A)APK A 35 ( 3.7A)APK A 35 ( 4.1A)NoneAPK A 35 ( 3.4A) | 0.58A | 3qwuA-2hvqA:11.8 | 3qwuA-2hvqA:23.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2owo | DNA LIGASE (Escherichiacoli) |
PF01653(DNA_ligase_aden)PF03119(DNA_ligase_ZBD)PF03120(DNA_ligase_OB)PF12826(HHH_2)PF14520(HHH_5) | 5 | GLU A 113LYS A 115ARG A 136GLU A 173VAL A 288 | None | 1.33A | 3qwuA-2owoA:10.3 | 3qwuA-2owoA:21.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2owo | DNA LIGASE (Escherichiacoli) |
PF01653(DNA_ligase_aden)PF03119(DNA_ligase_ZBD)PF03120(DNA_ligase_OB)PF12826(HHH_2)PF14520(HHH_5) | 5 | GLU A 113LYS A 115GLU A 173VAL A 288LYS A 290 | None | 0.97A | 3qwuA-2owoA:10.3 | 3qwuA-2owoA:21.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2p0a | SYNAPSIN-3 (Homo sapiens) |
PF02078(Synapsin)PF02750(Synapsin_C) | 5 | GLU A 284VAL A 226VAL A 246LYS A 248LYS A 260 | ANP A 707 (-3.7A)EDO A 601 (-3.9A)ANP A 707 ( 4.7A)ANP A 707 (-2.9A)None | 1.32A | 3qwuA-2p0aA:3.6 | 3qwuA-2p0aA:22.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pbe | AMINOGLYCOSIDE6-ADENYLYLTRANSFERASE (Bacillussubtilis) |
PF04439(Adenyl_transf) | 5 | TYR A 90GLU A 53GLU A 75PHE A 88VAL A 52 | None | 1.46A | 3qwuA-2pbeA:2.4 | 3qwuA-2pbeA:23.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2vug | PAB1020 (Pyrococcusabyssi) |
PF09414(RNA_ligase) | 10 | ILE A 71GLU A 93LYS A 95ASN A 100ARG A 115GLU A 147PHE A 172VAL A 200LYS A 232LYS A 241 | ANP A 401 (-4.3A)ANP A 401 (-4.0A)ANP A 401 (-3.0A)ANP A 401 (-3.8A)ANP A 401 (-3.0A)ANP A 401 (-2.8A)ANP A 401 (-3.5A)ANP A 401 (-4.5A)ANP A 401 (-2.9A)ANP A 401 (-2.8A) | 0.55A | 3qwuA-2vugA:43.4 | 3qwuA-2vugA:36.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3db2 | PUTATIVENADPH-DEPENDENTOXIDOREDUCTASE (Desulfitobacteriumhafniense) |
PF01408(GFO_IDH_MocA)PF02894(GFO_IDH_MocA_C) | 5 | TYR A 35ILE A 10GLU A 80GLU A 58VAL A 81 | None | 1.39A | 3qwuA-3db2A:undetectable | 3qwuA-3db2A:21.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3gde | DNA LIGASE (Archaeoglobusfulgidus) |
PF01068(DNA_ligase_A_M)PF04675(DNA_ligase_A_N)PF04679(DNA_ligase_A_C) | 6 | GLU A 247LYS A 249GLU A 298PHE A 337LYS A 400LYS A 417 | NonePO4 A 557 (-2.7A)NoneNoneNonePO4 A 556 ( 2.5A) | 0.89A | 3qwuA-3gdeA:10.8 | 3qwuA-3gdeA:21.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3l2p | DNA LIGASE 3 (Homo sapiens) |
PF01068(DNA_ligase_A_M)PF04675(DNA_ligase_A_N)PF04679(DNA_ligase_A_C) | 5 | GLU A 419ARG A 441GLU A 473VAL A 571LYS A 588 | AMP A 901 (-3.7A)NoneAMP A 901 ( 3.7A)AMP A 901 ( 4.8A)AMP A 901 (-2.9A) | 0.84A | 3qwuA-3l2pA:11.8 | 3qwuA-3l2pA:20.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3l2p | DNA LIGASE 3 (Homo sapiens) |
PF01068(DNA_ligase_A_M)PF04675(DNA_ligase_A_N)PF04679(DNA_ligase_A_C) | 6 | GLU A 419GLU A 473PHE A 508VAL A 571LYS A 573LYS A 588 | AMP A 901 (-3.7A)AMP A 901 ( 3.7A)AMP A 901 (-3.3A)AMP A 901 ( 4.8A)AMP A 901 (-3.1A)AMP A 901 (-2.9A) | 0.72A | 3qwuA-3l2pA:11.8 | 3qwuA-3l2pA:20.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3l2p | DNA LIGASE 3 (Homo sapiens) |
PF01068(DNA_ligase_A_M)PF04675(DNA_ligase_A_N)PF04679(DNA_ligase_A_C) | 5 | GLU A 419LYS A 421ARG A 441VAL A 571LYS A 588 | AMP A 901 (-3.7A)AMP A 901 (-2.2A)NoneAMP A 901 ( 4.8A)AMP A 901 (-2.9A) | 1.04A | 3qwuA-3l2pA:11.8 | 3qwuA-3l2pA:20.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3l2p | DNA LIGASE 3 (Homo sapiens) |
PF01068(DNA_ligase_A_M)PF04675(DNA_ligase_A_N)PF04679(DNA_ligase_A_C) | 5 | GLU A 419LYS A 421VAL A 571LYS A 573LYS A 588 | AMP A 901 (-3.7A)AMP A 901 (-2.2A)AMP A 901 ( 4.8A)AMP A 901 (-3.1A)AMP A 901 (-2.9A) | 0.97A | 3qwuA-3l2pA:11.8 | 3qwuA-3l2pA:20.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pn1 | DNA LIGASE (Haemophilusinfluenzae) |
PF01653(DNA_ligase_aden) | 5 | GLU A 114LYS A 116GLU A 174VAL A 289LYS A 291 | IVH A 319 (-3.6A)IVH A 319 (-3.7A)IVH A 319 (-2.9A)IVH A 319 (-4.4A)IVH A 319 (-3.0A) | 0.55A | 3qwuA-3pn1A:10.2 | 3qwuA-3pn1A:23.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rr5 | DNA LIGASE (Thermococcussp. 1519) |
PF01068(DNA_ligase_A_M)PF04675(DNA_ligase_A_N)PF04679(DNA_ligase_A_C) | 6 | GLU A 258LYS A 260GLU A 310PHE A 350LYS A 414LYS A 431 | None MG A 601 ( 4.8A)NoneNoneNoneNone | 0.76A | 3qwuA-3rr5A:10.6 | 3qwuA-3rr5A:22.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sgi | DNA LIGASE (Mycobacteriumtuberculosis) |
PF01653(DNA_ligase_aden)PF03120(DNA_ligase_OB) | 5 | GLU A 121ARG A 144GLU A 184VAL A 298LYS A 300 | AMP A 616 ( 3.9A)AMP A 616 (-3.8A)AMP A 616 (-3.7A)AMP A 616 (-4.6A)AMP A 616 ( 3.9A) | 1.00A | 3qwuA-3sgiA:10.4 | 3qwuA-3sgiA:19.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sgi | DNA LIGASE (Mycobacteriumtuberculosis) |
PF01653(DNA_ligase_aden)PF03120(DNA_ligase_OB) | 5 | GLU A 121LYS A 123ARG A 144VAL A 298LYS A 300 | AMP A 616 ( 3.9A)AMP A 616 (-1.6A)AMP A 616 (-3.8A)AMP A 616 (-4.6A)AMP A 616 ( 3.9A) | 1.31A | 3qwuA-3sgiA:10.4 | 3qwuA-3sgiA:19.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ty9 | POLYNUCLEOTIDE2',3'-CYCLICPHOSPHATEPHOSPHODIESTERASE /POLYNUCLEOTIDE5'-HYDROXYL-KINASE /POLYNUCLEOTIDE3'-PHOSPHATASE (Ruminiclostridiumthermocellum) |
PF16536(PNKP-ligase_C)PF16542(PNKP_ligase) | 6 | GLU A 529ARG A 565GLU A 607VAL A 772LYS A 774LYS A 792 | AMP A 900 (-4.0A)NoneAMP A 900 (-3.0A)AMP A 900 ( 4.8A)AMP A 900 (-3.2A)AMP A 900 (-2.8A) | 0.82A | 3qwuA-3ty9A:10.6 | 3qwuA-3ty9A:24.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ty9 | POLYNUCLEOTIDE2',3'-CYCLICPHOSPHATEPHOSPHODIESTERASE /POLYNUCLEOTIDE5'-HYDROXYL-KINASE /POLYNUCLEOTIDE3'-PHOSPHATASE (Ruminiclostridiumthermocellum) |
PF16536(PNKP-ligase_C)PF16542(PNKP_ligase) | 6 | GLU A 529GLU A 607PHE A 704VAL A 772LYS A 774LYS A 792 | AMP A 900 (-4.0A)AMP A 900 (-3.0A)AMP A 900 (-3.3A)AMP A 900 ( 4.8A)AMP A 900 (-3.2A)AMP A 900 (-2.8A) | 0.54A | 3qwuA-3ty9A:10.6 | 3qwuA-3ty9A:24.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ty9 | POLYNUCLEOTIDE2',3'-CYCLICPHOSPHATEPHOSPHODIESTERASE /POLYNUCLEOTIDE5'-HYDROXYL-KINASE /POLYNUCLEOTIDE3'-PHOSPHATASE (Ruminiclostridiumthermocellum) |
PF16536(PNKP-ligase_C)PF16542(PNKP_ligase) | 6 | GLU A 529LYS A 531ARG A 565GLU A 607VAL A 772LYS A 774 | AMP A 900 (-4.0A)AMP A 900 (-1.5A)NoneAMP A 900 (-3.0A)AMP A 900 ( 4.8A)AMP A 900 (-3.2A) | 0.95A | 3qwuA-3ty9A:10.6 | 3qwuA-3ty9A:24.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ty9 | POLYNUCLEOTIDE2',3'-CYCLICPHOSPHATEPHOSPHODIESTERASE /POLYNUCLEOTIDE5'-HYDROXYL-KINASE /POLYNUCLEOTIDE3'-PHOSPHATASE (Ruminiclostridiumthermocellum) |
PF16536(PNKP-ligase_C)PF16542(PNKP_ligase) | 6 | GLU A 529LYS A 531GLU A 607PHE A 704VAL A 772LYS A 774 | AMP A 900 (-4.0A)AMP A 900 (-1.5A)AMP A 900 (-3.0A)AMP A 900 (-3.3A)AMP A 900 ( 4.8A)AMP A 900 (-3.2A) | 0.71A | 3qwuA-3ty9A:10.6 | 3qwuA-3ty9A:24.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3w1g | DNA LIGASE 4 (Homo sapiens) |
PF01068(DNA_ligase_A_M)PF04675(DNA_ligase_A_N)PF04679(DNA_ligase_A_C) | 5 | GLU A 271LYS A 273ARG A 293VAL A 403LYS A 449 | ATP A 701 (-4.2A)ATP A 701 (-2.1A)SO4 A 709 ( 3.4A)NoneSO4 A 709 ( 2.8A) | 1.12A | 3qwuA-3w1gA:10.3 | 3qwuA-3w1gA:19.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3w1g | DNA LIGASE 4 (Homo sapiens) |
PF01068(DNA_ligase_A_M)PF04675(DNA_ligase_A_N)PF04679(DNA_ligase_A_C) | 6 | GLU A 271LYS A 273PHE A 367VAL A 403LYS A 432LYS A 449 | ATP A 701 (-4.2A)ATP A 701 (-2.1A)ATP A 701 (-3.6A)NoneATP A 701 (-3.5A)SO4 A 709 ( 2.8A) | 1.10A | 3qwuA-3w1gA:10.3 | 3qwuA-3w1gA:19.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3w1g | DNA LIGASE 4 (Homo sapiens) |
PF01068(DNA_ligase_A_M)PF04675(DNA_ligase_A_N)PF04679(DNA_ligase_A_C) | 5 | GLU A 331PHE A 367VAL A 403LYS A 432LYS A 449 | ATP A 701 (-3.4A)ATP A 701 (-3.6A)NoneATP A 701 (-3.5A)SO4 A 709 ( 2.8A) | 0.81A | 3qwuA-3w1gA:10.3 | 3qwuA-3w1gA:19.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4eq5 | DNA LIGASE (Thermococcussibiricus) |
PF01068(DNA_ligase_A_M)PF04675(DNA_ligase_A_N)PF04679(DNA_ligase_A_C) | 7 | GLU A 259LYS A 261ARG A 281GLU A 311PHE A 351LYS A 415LYS A 432 | AMP A 601 (-4.1A)AMP A 601 (-3.8A)AMP A 601 (-3.3A)AMP A 601 (-3.5A)AMP A 601 (-3.3A)AMP A 601 (-2.8A)AMP A 601 (-3.5A) | 0.86A | 3qwuA-4eq5A:10.9 | 3qwuA-4eq5A:23.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4glw | DNA LIGASE (Streptococcuspneumoniae) |
PF01653(DNA_ligase_aden) | 5 | GLU A 107LYS A 109GLU A 164VAL A 276LYS A 278 | 0XT A 402 (-3.7A)0XT A 402 ( 4.4A)0XT A 402 ( 4.5A)0XT A 402 (-4.6A)0XT A 402 (-2.8A) | 0.52A | 3qwuA-4glwA:10.5 | 3qwuA-4glwA:22.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4glx | DNA LIGASE (Escherichiacoli) |
PF01653(DNA_ligase_aden)PF03119(DNA_ligase_ZBD)PF03120(DNA_ligase_OB)PF12826(HHH_2)PF14520(HHH_5) | 5 | GLU A 113LYS A 115ARG A 136GLU A 173VAL A 288 | 0XS A 603 (-4.0A)0XS A 603 (-4.3A)None0XS A 603 (-3.5A)0XS A 603 (-4.6A) | 1.13A | 3qwuA-4glxA:10.1 | 3qwuA-4glxA:23.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4glx | DNA LIGASE (Escherichiacoli) |
PF01653(DNA_ligase_aden)PF03119(DNA_ligase_ZBD)PF03120(DNA_ligase_OB)PF12826(HHH_2)PF14520(HHH_5) | 5 | GLU A 113LYS A 115GLU A 173VAL A 288LYS A 290 | 0XS A 603 (-4.0A)0XS A 603 (-4.3A)0XS A 603 (-3.5A)0XS A 603 (-4.6A)0XS A 603 (-2.9A) | 0.53A | 3qwuA-4glxA:10.1 | 3qwuA-4glxA:23.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4lh7 | DNA LIGASE (Enterococcusfaecalis) |
PF01653(DNA_ligase_aden) | 5 | GLU A 118LYS A 120GLU A 175VAL A 289LYS A 291 | 1X8 A 401 (-3.4A)1X8 A 401 (-3.6A)1X8 A 401 (-3.6A)1X8 A 401 ( 4.3A)1X8 A 401 (-2.7A) | 0.58A | 3qwuA-4lh7A:9.9 | 3qwuA-4lh7A:22.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4lh7 | DNA LIGASE (Enterococcusfaecalis) |
PF01653(DNA_ligase_aden) | 5 | TYR A 87GLU A 118LYS A 120VAL A 289LYS A 291 | 1X8 A 401 (-4.4A)1X8 A 401 (-3.4A)1X8 A 401 (-3.6A)1X8 A 401 ( 4.3A)1X8 A 401 (-2.7A) | 0.94A | 3qwuA-4lh7A:9.9 | 3qwuA-4lh7A:22.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4oah | MITOCHONDRIALDYNAMIC PROTEINMID51 (Mus musculus) |
PF03281(Mab-21) | 5 | ARG A 326GLU A 437PHE A 230VAL A 227VAL A 432 | None | 1.11A | 3qwuA-4oahA:undetectable | 3qwuA-4oahA:22.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xru | RNL (Capnocytophagagingivalis) |
PF16542(PNKP_ligase) | 7 | ILE B 26GLU B 59GLU B 120PHE B 234VAL B 297LYS B 299LYS B 313 | ATP B 501 (-4.0A)ATP B 501 (-3.8A)ATP B 501 ( 2.9A)ATP B 501 (-3.4A)NoneATP B 501 (-3.5A)ATP B 501 (-2.4A) | 0.92A | 3qwuA-4xruB:10.4 | 3qwuA-4xruB:22.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xru | RNL (Capnocytophagagingivalis) |
PF16542(PNKP_ligase) | 7 | ILE B 26GLU B 59LYS B 61GLU B 120PHE B 234VAL B 297LYS B 299 | ATP B 501 (-4.0A)ATP B 501 (-3.8A)ATP B 501 (-2.3A)ATP B 501 ( 2.9A)ATP B 501 (-3.4A)NoneATP B 501 (-3.5A) | 1.12A | 3qwuA-4xruB:10.4 | 3qwuA-4xruB:22.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cov | NAEGLERIA GRUBERIRNA LIGASE (Naegleriagruberi) |
PF09414(RNA_ligase) | 6 | GLU A 227PHE A 248VAL A 281VAL A 315LYS A 317LYS A 326 | MN A 401 ( 4.5A)NoneNoneNoneNoneNone | 0.60A | 3qwuA-5covA:13.9 | 3qwuA-5covA:21.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5d1p | ATP-DEPENDENT RNALIGASE (Methanothermobacterthermautotrophicus) |
PF09414(RNA_ligase) | 10 | ILE A 74GLU A 95ASN A 102ARG A 118GLU A 151PHE A 175VAL A 203VAL A 234LYS A 236LYS A 246 | APK A 97 (-4.3A)APK A 97 ( 4.2A)APK A 97 ( 3.8A)SO4 A 502 (-3.2A)APK A 97 ( 3.0A)APK A 97 ( 3.5A)APK A 97 ( 4.7A)APK A 97 ( 4.3A)APK A 97 ( 3.3A)SO4 A 501 ( 2.7A) | 0.47A | 3qwuA-5d1pA:39.9 | 3qwuA-5d1pA:30.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fpr | DNA LIGASE (Staphylococcusaureus) |
PF01653(DNA_ligase_aden) | 5 | LYS A 112ARG A 133GLU A 167VAL A 281LYS A 283 | NoneNoneSO4 A1311 ( 4.8A)NoneNone | 0.99A | 3qwuA-5fprA:10.3 | 3qwuA-5fprA:23.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vn4 | ADENINEPHOSPHORIBOSYLTRANSFERASE, PUTATIVE (Trypanosomabrucei) |
PF00156(Pribosyltran) | 5 | ILE A 76GLU A 171PHE A 62VAL A 201VAL A 143 | None | 1.47A | 3qwuA-5vn4A:undetectable | 3qwuA-5vn4A:21.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gdr | - (-) |
no annotation | 5 | LYS A 34GLU A 73PHE A 133VAL A 164LYS A 209 | None | 0.68A | 3qwuA-6gdrA:9.8 | 3qwuA-6gdrA:undetectable |